China-based Youwe (Zhuhai) Biotechnology Co., Ltd, a developer of soluble microneedle transdermal drug delivery technology, has reportedly raised close to RMB 100 million (USD 14.9 million) in a Series B financing round. Cenova Ventures was the sole investor. The proceeds will be used for the commercialization of soluble microneedle technology in the consumer sector and business expansion and manufacturing capability building in the pharmaceutical field.
Company Technology
Youwe Bio boasts the third-generation soluble microneedle patented technology, “high-pressure jet filling process.” This technology enables the stable mass production of one-piece base large-capacity drug-loaded patches and segmented needle-tip precise and quantitative drug-loaded patches.-Fineline Info & Tech
